However, the bioinformatic analysis with the TCGA cohort only and another larger cohort integrated by Kaplan-Meier Plotter showed differential impact of PREX2 on the prognosis of distinct NSCLC patient subgroups (Figure S1). Here, PREX2 is linked to non-small cell lung carcinoma.